Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
Administrative Core-Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
批准号:
10677826
负责人:
William Mallory Grady
金额:
$41.74万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-05 至 2027-07-31
关键词:
Administrative CoordinationAdministratorBiological AssayBiological MarkersCLIA certifiedCancer Intervention and Surveillance Modeling NetworkClinicalCollaborationsCommunicationDataData AnalysesData CommonsData Coordinating CenterDevelopmentEarly Detection Research NetworkEarly DiagnosisEducationEnvironmentFundingFunding AgencyFutureIndustrializationInstitutionLettersMalignant neoplasm of esophagusMalignant neoplasm of gastrointestinal tractMissionProcessProductivityRanaResearchResearch PersonnelRunningScientistScreening for cancerStructureSystemTeleconferencesUnited States National Institutes of HealthValidationWorkbiomarker discoverybiomarker validationclinical biomarkersclinical developmentcolon cancer screeningdata disseminationdata sharingdata submissionindustry partnerinnovationinterestmeetingsmemberoperationorganizational structureprogramsprotocol developmentrisk predictionsuccessvalidation studies
中文摘要
项目总结
我们的生物标记表征中心(BCC)的管理核心(AC)将促进和优化
整合生物标记物发现和初步验证研究,由生物标记物发现实验室(BDL)和
开发和验证研究以创建临床级别的、符合CLIA标准的生物标记物分析
生物标记参考实验室(BRL)。管理核心将由中心管理员管理并运行
由BDL和BRL的PI。它将支持和加强跨BCC和跨EDRN通信、数据
传播以及数据审查和分析,这将促进BCC的核心使命,即发现和验证
临床分级生物标志物分析用于胃肠道癌症风险预测和早期发现行政核心将
为EDRN BCC和临床部之间的协作和沟通提供行政支持
验证中心(CVC)、数据管理中心(DMCC);协作行业合作伙伴(例如Cernostics、
QIAGEN等)和学术合作伙伴,以及合作的NCI项目(例如,CISNET、NIST等)。通过
行政核心、BCC与其他EDRN BCC、CVC和DMCC、行业合作伙伴以及
学术伙伴不仅将在BCC的研究上合作,而且还将在由此产生的衍生品研究和
其他EDRN BCC和CVC项目,源于BCC的高度创新、多产和重要的
用于GI癌风险预测和早期检测的生物标记物发现和验证程序及其程序
其他商业信贷资料库。
行政核心有以下目标:
目标1:提供组织结构,以支持BCC的关键目标,即BDL的目标
以及BRL的科学和教育使命以及BDL和BRL Pi之间的成功合作
科学家、EDRN合作伙伴、学术合作伙伴和产业合作伙伴。
目标2:为大型协作研究工作提供高效的管理,涉及多个
各机构和多个个人数字助理/个人数字助理,包括地方和国家会议管理。
目标3:与EDRN DMCC协调制定方案、共享生物胺、生物胺盲法、
数据分析、数据共享、数据存储、填充Biomarker数据共享空间以及任何其他相关
被认为是BCC运营以及更大网络所必需的功能。
英文摘要
PROJECT SUMMARY
The Administrative Core (AC) of our Biomarker Characterization Center (BCC) will facilitate and optimize
the integration of biomarker discovery and initial validation studies by the Biomarker Discovery Lab (BDL) and
the development and validation studies to create clinical-grade, CLIA compliant biomarker assays by the
Biomarker Reference Lab (BRL). The Administrative Core will be managed by the Center Administrator and run
by the PIs of the BDL and BRL. It will support and enhance cross BCC and cross EDRN communication, data
dissemination and data review and analysis, which will promote the BCC’s core mission to discovery and validate
clinical grade biomarker assays for GI cancer risk prediction and early detection The Administrative Core will
provide administrative support for collaborations and communications between the EDRN BCCs, Clinical
Validation Centers (CVCs), Data Management Center (DMCC); collaborating industrial partners (e.g. Cernostics,
Qiagen, etc.) and academic partners, and collaborating NCI programs (e.g. CISNET, NIST, etc.). Through the
functions of the Administrative Core, the BCC with other EDRN BCCs, CVC, and DMCC, industrial partners, and
academic partners will collaborate not only on the BCC’s studies but also on resulting derivative studies and
other EDRN BCC and CVC projects that arise from the BCC’s highly innovative, productive and significant
program of biomarker discovery and validation for GI cancer risk prediction and early detection and the programs
of other BCCs.
The Administrative Core has the following aims:
Aim 1: To provide the organizational structure for supporting the key objectives of the BCC, which are the BDL’s
and BRL’s scientific and educational missions and the successful collaboration among the BDL and BRL PI and
scientists, EDRN partners, academic partners and industrial partners.
Aim 2: To provide efficiency in management of large-scale collaborative research efforts involving multiple
institutions and multiple PDs/PIs, including local and national meetings management.
Aim 3: To coordinate with EDRN DMCC for protocol development, biospecimen sharing, biospecimen blinding,
data analysis, data sharing, data deposition, populating Biomarker Data Commons, and any other relevant
functions deemed necessary for BCC operations as well as for the larger Network.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10519073
-
项目类别:
-
资助金额:$8.34万
-
财政年份:2022
-
负责人:William Mallory Grady
-
依托单位:
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
-
批准号:10707100
-
项目类别:
-
资助金额:$50.34万
-
财政年份:2022
-
负责人:William Mallory Grady
-
依托单位:
Biomarker Development Laboratory
-
批准号:10677827
-
项目类别:
-
资助金额:$32.76万
-
财政年份:2022
-
负责人:William Mallory Grady
-
依托单位:
Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus
-
批准号:10677825
-
项目类别:
-
资助金额:$100.92万
-
财政年份:2022
-
负责人:William Mallory Grady
-
依托单位:
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
-
批准号:10920978
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2022
-
负责人:William Mallory Grady
-
依托单位:
Administrative Core
-
批准号:10707097
-
项目类别:
-
资助金额:$33.59万
-
财政年份:2022
-
负责人:William Mallory Grady
-
依托单位:
Comprehensive atlas of advanced adenomas and their surrounding primed colon: A multi-omics evaluation and clinical impact assessment
-
批准号:10519074
-
项目类别:
-
资助金额:$67.95万
-
财政年份:2022
-
负责人:William Mallory Grady
-
依托单位:
Liver Cancer Disparities in Alaska Native and American Indian People
-
批准号:10286757
-
项目类别:
-
资助金额:$101.15万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
The intestinal microbiome contribution to colon cancer and senescence
-
批准号:10831334
-
项目类别:
-
资助金额:$18.33万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
The role of the senescent microenvironment on cancer initiating cells in the colon.
-
批准号:10638374
-
项目类别:
-
资助金额:$6.94万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
Novel biomarker strategies for HCC early detection in AI/AN patients
-
批准号:10706313
-
项目类别:
-
资助金额:$13.63万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
Liver Cancer Disparities in Alaska Native and American Indian People
-
批准号:10706310
-
项目类别:
-
资助金额:$82.84万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
Novel biomarker strategies for HCC early detection in AI/AN patients
-
批准号:10482367
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
Novel biomarker strategies for HCC early detection in AI/AN patients
-
批准号:10286759
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
Liver Cancer Disparities in Alaska Native and American Indian People
-
批准号:10482365
-
项目类别:
-
资助金额:$85.02万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
The role of the senescent microenvironment on cancer initiating cells in the colon.
-
批准号:10355956
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2021
-
负责人:William Mallory Grady
-
依托单位:
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
-
批准号:9761849
-
项目类别:
-
资助金额:$67.82万
-
财政年份:2017
-
负责人:William Mallory Grady
-
依托单位:
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
-
批准号:10228657
-
项目类别:
-
资助金额:$49.15万
-
财政年份:2017
-
负责人:William Mallory Grady
-
依托单位:
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
-
批准号:9379369
-
项目类别:
-
资助金额:$73.9万
-
财政年份:2017
-
负责人:William Mallory Grady
-
依托单位:
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
-
批准号:10004508
-
项目类别:
-
资助金额:$54.43万
-
财政年份:2017
-
负责人:William Mallory Grady
-
依托单位:
海外基金